Evidence map›Paper›PMID 40739316›Full record

ArticleScientific reports2025

The phosphatases TCPTP, PTPN22, and SHP1 play unique roles in T cell phosphotyrosine maintenance and feedback regulation of the TCR.

Aurora Callahan, Aisharja Mojumdar, Mengzhou Hu, Amber Wang, Alijah A Griffith, Nicholas Huang, Xien Yu Chua, Nick Mroz, Ryan Z Puterbaugh, Shanelle P Reilly and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Aurora CallahanDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, 02903, USA.
Aisharja MojumdarDepartment of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI, 02903, USA.
Mengzhou HuDepartment of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI, 02903, USA.
Amber WangDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, 02903, USA.
Alijah A GriffithDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, 02903, USA.
Nicholas HuangDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, 02903, USA.
Xien Yu ChuaDepartment of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI, 02903, USA.
Nick MrozDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, 02903, USA.
Ryan Z PuterbaughDepartment of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, RI, 02903, USA.
Shanelle P ReillyDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, 02903, USA.
Arthur SalomonDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, 02903, USA. art@drsalomon.com.

Funding

Understand the metabolic fitness of naïve T cellsP01AI091580 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JEROEN ROOSE · 2011 to 2026
$31.1M
Translational Regulation in Normal Erythropoiesis and Diamond Blackfan AnemiaP20GM121293 · NIGMS · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI Alan Tackett · 2017 to 2026
$27.6M
Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
Phosphoproteomic Analysis of T Cell Activation PathwaysR01AI083636 · NIAID · BROWN UNIVERSITY · PI SALOMON, ARTHUR ROBERT · 2010 to 2021
$4.0M
Predoctoral Training in Molecular, Cellular, and Biochemical SciencesT32GM136566 · NIGMS · BROWN UNIVERSITY · PI Mark Aikens Johnson, Erica Nicole Larschan · 2020 to 2026
$3.1M
Acquisition of an Eclipse Tribrid Mass Spectometer System to Advance Proteomics Research in Rhode IslandS10OD036295 · OD · BROWN UNIVERSITY · PI SALOMON, ARTHUR ROBERT · 2024 to 2024
$1.2M
NIAID NIH HHS P01 AI091580NIAID NIH HHS R01 AI083636NIGMS NIH HHS P20 GM121293NIGMS NIH HHS R24 GM137786NIGMS NIH HHS T32 GM136566NIH HHS R01AI083636NIH HHS S10 OD036295
6 · The paper itself

Abstract

The protein tyrosine phosphatases (PTPs) TCPTP, PTPN22, and SHP1 are critical regulators of the activating phosphotyrosine (pY) site on the initiating T cell kinase, Lck

Indexed as

PhosphotyrosineProtein Tyrosine Phosphatase, Non-Receptor Type 22Protein Tyrosine Phosphatase, Non-Receptor Type 6Receptors, Antigen, T-CellT-LymphocytesCRISPR-Cas SystemsFeedback, PhysiologicalHumansJurkat CellsProtein Tyrosine Phosphatase, Non-Receptor Type 1Signal TransductionPhosphotyrosineProtein Tyrosine Phosphatase, Non-Receptor Type 1Protein Tyrosine Phosphatase, Non-Receptor Type 22Protein Tyrosine Phosphatase, Non-Receptor Type 6PTPN1 protein, humanPTPN22 protein, humanReceptors, Antigen, T-CellMass spectrometryNegative feedbackPositive feedbackProtein tyrosine phosphatasesT cell signallingTyrosine phosphorylation

Identifiers

PMID40739316
PMCPMC12311025

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.